Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Update

Autonomix Medical, Inc. (NASDAQ:AMIX) was the target of a large decrease in short interest in June. As of June 15th, there was short interest totaling 344,031 shares, a decrease of 46.8% from the May 31st total of 646,074 shares. Based on an average daily volume of 146,755 shares, the short-interest ratio is presently 2.3 days. Currently, 5.3% of the shares of the stock are short sold.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on AMIX shares. Weiss Ratings upgraded Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a report on Tuesday, June 23rd. Zacks Research upgraded shares of Autonomix Medical to a “hold” rating in a report on Tuesday, June 2nd. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $42.00.

Autonomix Medical Stock Performance

Shares of NASDAQ:AMIX opened at $5.84 on Tuesday. Autonomix Medical has a 52 week low of $4.20 and a 52 week high of $55.44. The firm has a market cap of $3.15 million, a PE ratio of -0.08 and a beta of -1.44. The firm’s fifty day moving average is $7.76 and its 200-day moving average is $9.01.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.